Evidence map›Paper›PMID 23509421›Full record

ArticleSarcoma2013

Can bone tissue engineering contribute to therapy concepts after resection of musculoskeletal sarcoma?

Boris Michael Holzapfel, Mohit Prashant Chhaya, Ferry Petrus Wilhelmus Melchels, Nina Pauline Holzapfel, Peter Michael Prodinger, Ruediger von Eisenhart-Rothe, Martijn van Griensven, Jan-Thorsten Schantz, Maximilian Rudert, Dietmar Werner Hutmacher

Open access · hybridAbstract read
In one paragraph

Article in Sarcoma, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Long-term in vitro degradation and in vivo evaluation of resorbable bioceramics.Journal of materials science. Materials in medicine · 2021
    Article
  5. Graphene and its Derivatives for Bone Tissue Engineering:Frontiers in bioengineering and biotechnology · 2021
    Review
  6. Article
  7. Scaffolds and coatings for bone regeneration.Journal of materials science. Materials in medicine · 2020
    Review
  8. Reconstructive Science in Orthopedic Oncology.Techniques in orthopaedics (Rockville, Md.) · 2018
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Boris Michael HolzapfelRegenerative Medicine Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove, QLD 4049, Australia ; Department of Orthopaedic Surgery, König-Ludwig-Haus, Orthopaedic Center for Musculoskeletal Research, University of Würzburg, Brettreich Straße 11, 97072 Würzburg, Germany.
Mohit Prashant Chhaya
Ferry Petrus Wilhelmus Melchels
Nina Pauline Holzapfel
Peter Michael Prodinger
Ruediger von Eisenhart-Rothe
Martijn van Griensven
Jan-Thorsten Schantz
Maximilian Rudert
Dietmar Werner Hutmacher
Klinikum rechts der Isar · DEQueensland University of Technology · AUGeorgia Institute of Technology · USHeidelberg University · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resection of musculoskeletal sarcoma can result in large bone defects where regeneration is needed in a quantity far beyond the normal potential of self-healing. In many cases, these defects exhibit a limited intrinsic regenerative potential due to an adjuvant therapeutic regimen, seroma, or infection. Therefore, reconstruction of these defects is still one of the most demanding procedures in orthopaedic surgery. The constraints of common treatment strategies have triggered a need for new therapeutic concepts to design and engineer unparalleled structural and functioning bone grafts. To satisfy the need for long-term repair and good clinical outcome, a paradigm shift is needed from methods to replace tissues with inert medical devices to more biological approaches that focus on the repair and reconstruction of tissue structure and function. It is within this context that the field of bone tissue engineering can offer solutions to be implemented into surgical therapy concepts after resection of bone and soft tissue sarcoma. In this paper we will discuss the implementation of tissue engineering concepts into the clinical field of orthopaedic oncology.

Identifiers

PMID23509421
PMCPMC3556880
OpenAlexW2055842151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.